Pre-Market Commentary: Perrigo, Allscripts Healthcare Solutions, Catalyst Pharma Partners, and Ironwood Pharma

  Pre-Market Commentary: Perrigo, Allscripts Healthcare Solutions, Catalyst
                     Pharma Partners, and Ironwood Pharma

PR Newswire

LONDON, December 23, 2013

LONDON, December 23, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

On Friday, December 20, 2013, the U.S. equity market edged higher, The S&P 500
ended the day at1,818.32, up 0.48%; the Dow Jones Industrial Average closed
at 16,221.14, up 0.26%; and the NASDAQ Composite finished at4,104.74, up
1.15%. Moreover, the S&P 500 Health Care Sector Index closed the day at
635.97, up 0.45%; and the same edged up 2.63% in the previous three trading
sessions and 7.23% in the last three months, outperforming the S&P 500, which
has gained 2.10% and 6.84%, during the respective periods.The major movers in
the sector included Perrigo Company PLC (NYSE: PRGO), Allscripts Healthcare
Solutions Inc. (NASDAQ: MDRX), Catalyst Pharmaceutical Partners Inc. (NASDAQ:
CPRX), and Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD). All these companies
are tracked by AAAResearchReports.com. Download free technical analysis and
charting reports on PRGO, MDRX, CPRX, and IRWD now at:

http://www.aaaresearchreports.com/register/

On Friday, Perrigo Co. PLC's stock advanced to end the day at $152.26, which
is 0.74% higher than the previous day's closing price of $151.14. The
company's shares vacillated between $148.15 and $152.26 during the trading
session. A total of 3.17 million shares were traded, which is above the daily
average volume of 1.35 million. The company's shares have gained 21.83% in the
previous three months, outperforming the S&P 500, which has advanced 6.84%,
during the same period. Furthermore, Perrigo Co. PLC's stock is trading above
its 50-day and 200-day moving averages of $145.81 and $127.65, respectively.
Download free research on PRGO today by registering at:

http://www.AAAResearchReports.com/PRGO122313.pdf

Shares in Allscripts Healthcare Solutions Inc. edged 0.74% higher on Friday,
closing the day at $15.02, after oscillating between $14.84 and $15.06. A
total of 1.95 million shares were traded, which is above the daily average
volume of 1.76 million. The company's shares have advanced 0.40% in the
previous three trading sessions and 2.95% in the last one month, compared to a
gain of 2.10% and 0.75% in the S&P 500 during the respective periods.
Furthermore, Allscripts Healthcare Solutions Inc.'s stock is trading above its
50-day and 200-day moving averages of $14.66 and $14.32, respectively. Sign up
and have access to our free report on MDRX at:

http://www.AAAResearchReports.com/MDRX122313.pdf

On Friday, shares in Catalyst Pharma Partners Inc. declined 2.34%, even as the
broader market posted gains. The company's shares finished the day at $1.88,
after trading between $1.83 and $1.92. A total of 0.64 million shares were
traded, which is below the daily average volume of 1.84 million. Despite
Friday's decline, the company's shares have advanced 9.30% in the last one
month, outperforming the S&P 500, which has gained 0.75%, during the same
period. Furthermore, Catalyst Pharma Partners Inc.'s stock is trading above
its 50-day and 200-day moving averages of 1.84 and $1.42, respectively. Sign
up and read the complimentary report on CPRX at:

http://www.AAAResearchReports.com/CPRX122313.pdf

Ironwood Pharmaceuticals Inc.'s stock surged on Friday, to end the day at
$11.76, up 4.63% from the previous day's closing price of $11.24. The
company's shares fluctuated between $10.96 and $11.83 during the trading
session. A total of 2.36 million shares were traded, which is above the daily
average volume of 1.06 million. The company's shares have gained 10.11% in the
previous three trading sessions and 11.15% in the last one month,
outperforming the S&P 500, which has advanced 2.10% and 0.75% during the
respective periods. Moreover, Ironwood Pharmaceuticals Inc.'s stock is trading
above its 50-day moving average of $10.48. The free report on IRWD can be
downloaded by signing up now at:

http://www.AAAResearchReports.com/IRWD122313.pdf

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are
    only human and are prone to make mistakes. If you notice any errors or
    omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Ananya Ghosh, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
Institute.

http://www.AAAResearchReports.com/

SOURCE AAA Research Reports

Contact: Contact Name: Peter F. Jones - Phone #: +1(646)396-9126, Email ID:
info@aaaresearchreports.com